10-Q: Xylem Inc. Reports Strong Q2 2024 Results Driven by Organic Growth and Evoqua Acquisition
Quarterly Report
Xylem Inc. announced a significant increase in revenue and earnings for the second quarter of 2024, boosted by organic growth and the acquisition of Evoqua Water Technologies Corp.
Summary
- Xylem's revenue for the second quarter of 2024 reached $2.169 billion, a 26% increase compared to the same period last year.
- This growth was driven by a 9.2% organic increase and $302 million from acquisitions and divestitures.
- The company's net income for the quarter was $194 million, a substantial rise from $92 million in the prior year.
- Earnings per share were reported at $0.80, up from $0.45 in the second quarter of 2023.
- Adjusted EBITDA margin improved to 20.8%, a 170 basis point increase year-over-year.
- Orders for the quarter totaled $2.087 billion, a 12.4% increase, although organic orders decreased by 1.2%.
- The company's backlog stands at $5.156 billion as of June 30, 2024.
Sentiment
Score: 8
Explanation: The document presents a very positive outlook with strong financial results, significant growth, and improved profitability. While there are some challenges noted, the overall tone is optimistic and indicates a healthy business trajectory.
Positives
- Strong revenue growth across all segments, particularly in Water Solutions and Services.
- Significant increase in net income and earnings per share.
- Improved adjusted EBITDA margin, indicating enhanced profitability.
- Positive impact from the Evoqua acquisition on overall financial performance.
- Strong performance in the Measurement and Control Solutions segment, driven by increased sales volume and backlog execution.
- The company has available liquidity of approximately $1.8 billion.
Negatives
- Organic orders decreased by 1.2% in the second quarter.
- Applied Water segment revenue decreased by 4.6% due to softness in the U.S. and Western Europe.
- Gross margin remained flat at 37.8% for the quarter, and decreased 40 basis points to 37.4% for the six months ended June 30, 2024.
- The company incurred $29 million in restructuring and realignment costs in the second quarter.
- The company incurred $13 million in special charges in the second quarter.
Risks
- The company is exposed to fluctuations in foreign currency exchange rates.
- There are risks associated with the integration of the Evoqua acquisition.
- The company faces potential supply chain disruptions and cost increases.
- The company is subject to various legal and regulatory proceedings.
- The company is exposed to risks related to cybersecurity incidents and disruptions of information technology systems.
- The company is exposed to risks related to its sustainability commitments and related disclosures.
Future Outlook
Xylem is updating its total revenue growth to be 16%, and organic revenue growth to be in the range of 5% to 6% in 2024. The outlook reflects current visibility and expectations based on the current market environment and other factors.
Management Comments
- Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others.
- Management considers certain non-GAAP measures to be useful to management and investors evaluating operating performance.
Industry Context
The results reflect a strong performance in the water technology sector, with Xylem benefiting from increased demand and the strategic acquisition of Evoqua. The company's focus on water infrastructure, applied water, and smart metering solutions aligns with global trends towards water conservation and efficient resource management.
Comparison to Industry Standards
- Xylem's revenue growth of 26% in Q2 2024 is significantly higher than the average growth rate for companies in the industrial sector, which is estimated to be in the single digits.
- The adjusted EBITDA margin of 20.8% is competitive with other leading companies in the water technology industry, such as Danaher and Ecolab, which typically report margins in the range of 18-22%.
- The company's organic growth of 9.2% is a positive indicator of its underlying business strength, compared to peers that rely more heavily on acquisitions for growth.
- Xylem's backlog of $5.156 billion provides a strong foundation for future revenue, which is comparable to other large infrastructure companies with long-term contracts.
- The company's performance in the Measurement and Control Solutions segment, with a 25.5% revenue increase, is indicative of the growing demand for smart metering and water analytics solutions, which is a key trend in the industry.
Legal Proceedings
- Evoqua and the USAO entered into a non-prosecution agreement to resolve an investigation, with Evoqua paying a criminal monetary penalty of $8.5 million.
Stakeholder Impact
- Shareholders will benefit from increased earnings per share and improved profitability.
- Employees may see opportunities for growth and development due to the company's expansion.
- Customers will benefit from the company's enhanced product and service offerings.
- Suppliers may see increased business opportunities due to the company's growth.
- Creditors will benefit from the company's improved financial health and liquidity.
Next Steps
- The company expects to recognize approximately 40% of its backlog as revenue in the remainder of 2024.
- The company will continue to monitor its global funding requirements and seek to meet its liquidity needs on a cost-effective basis.
- The company will continue to evaluate aspects of its spending, including capital expenditures, strategic investments and dividends.
Key Dates
| Date | Description |
|---|---|
| 2011-09-02 | Date related to a previous credit facility. |
| 2015-08-24 | Date of authorization of a share repurchase program. |
| 2016-10-11 | Date of issuance of Senior Notes due 2026 and 2046. |
| 2019-06-03 | Date Xylem entered into a Euro commercial paper program. |
| 2020-06-26 | Date of issuance of Senior Notes due 2028 and 2031. |
| 2021-04-01 | Date Evoqua Finance LLC entered into an accounts receivable securitization program. |
| 2023-01-01 | Effective date of change to reportable segments. |
| 2023-01-22 | Date of the Merger Agreement with Evoqua. |
| 2023-03-01 | Date Xylem entered into a five-year revolving credit facility. |
| 2023-05-09 | Date Xylem Europe GmbH entered into a term loan facility. |
| 2023-05-24 | Date Xylem completed the acquisition of Evoqua. |
| 2023-06-15 | Date Xylem sold the former Evoqua carbon reactivation and slurry operations. |
| 2024-04-19 | Date the Term Loan Facility was settled. |
| 2024-06-30 | End of the quarterly period covered by the report. |
| 2024-07-26 | Date of outstanding shares of common stock. |
Keywords
Xylem, Evoqua, Water Technology, Financial Results, Quarterly Report, Revenue Growth, Net Income, EBITDA, Organic Growth, Water Infrastructure, Applied Water, Measurement and Control Solutions, Water Solutions and Services, Acquisition, Orders, Backlog
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.